Skip to main content
TipRanks
Go Ultimate75% OFF

MIKOBEAUTE INTERNATIONAL CO., LTD. (6574) AI Stock Analysis

TW:6574

MIKOBEAUTE INTERNATIONAL CO., LTD.

(TPEx:6574)

Select Model
Rating:67Neutral
Price Target:TWD 105.00â–¼(-10.26% Downside)
Action:initiatedcoverage
Date:11/10/26

Strong valuation and solid financial position with low leverage and improving margins are primary positives; weak technicals showing sustained downtrend and softer free cash flow are key offsets.

Positive Factors
Strong profitabilityThe company’s high gross, operating, and net margins indicate strong economics in its beauty and personal care activities. If maintained, this profitability provides room to fund product development, distribution, and growth while supporting resilience against operating pressures.
Negative Factors
Weak free cash flow conversionThe sharp decline in free cash flow means accounting profitability translated into substantially less discretionary cash in 2025. Persistently weaker conversion could constrain reinvestment, dividends, or debt reduction and makes future cash generation an important durability risk.

MIKOBEAUTE INTERNATIONAL CO., LTD. (6574) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%TW:6574+60.66%SPY+14.28%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
TWD 2.47B
Dividend Yield
2.56%
Average Volume (3M)
42.14K
Price to Earnings (P/E)
8.7
Beta (1Y)
0.27
Revenue Growth
20.16%
EPS Growth
136.85%
Country
TW
Employees
543
Sector
General
Sector Strength
55
Industry
Household & Personal Products

MIKOBEAUTE INTERNATIONAL CO., LTD. Business Overview & Revenue Model

Company Description

Mikobeaute International Co., Ltd. specializes in the distribution and direct sale of cosmetic products, reaching customers both in Taiwan and across international borders. The company markets its diverse range of beauty solutions under several brand...

MIKOBEAUTE INTERNATIONAL CO., LTD. Financial Statement Overview

Summary

Profitability strengthened with 24.1% net margin and 28.3% EBIT margin; balance sheet resilient with low 0.15 debt-to-equity and 16.8% ROE. Offset by gross margin compression and 32% drop in free cash flow.

Income Statement

72Positive

Balance Sheet

86Very Positive

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Mar 2023Dec 2021
Income Statement
Total Revenue734.05M621.68M583.69M620.02M681.25M648.27M
Gross Profit379.36M355.15M431.64M479.49M526.17M496.37M
EBITDA336.06M246.90M163.48M127.27M172.34M86.10M
Net Income291.14M149.91M90.26M46.52M68.05M13.82M
Balance Sheet
Total Assets1.35B1.11B834.37M844.12M925.38M897.07M
Cash, Cash Equivalents and Short-Term Investments659.31M439.78M486.98M578.00M579.61M511.61M
Total Debt120.43M134.51M79.47M87.95M138.74M133.57M
Total Liabilities283.84M213.10M164.40M202.96M252.34M266.64M
Stockholders Equity1.07B892.46M669.97M641.16M666.04M624.80M
Cash Flow
Free Cash Flow211.88M28.16M113.80M145.21M135.69M40.85M
Operating Cash Flow305.74M158.32M124.82M149.28M164.78M73.42M
Investing Cash Flow-74.44M15.21M-98.46M-610.00K-66.11M33.35M
Financing Cash Flow-87.09M-92.47M-111.40M-129.13M-81.31M-60.80M

MIKOBEAUTE INTERNATIONAL CO., LTD. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

TW:6574 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TW:4138TW:413868NeutralTWD 2.15B15.66―7.75%-1.10%-16.90%
TW:6574TW:657467NeutralTWD 2.39B8.69―2.56%20.16%136.85%
TW:2937TW:293757NeutralTWD 2.06B10.50―3.99%12.09%10.86%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
TW:1325TW:132541NeutralTWD 2.16B-42.66―1.19%-21.19%47.07%
TW:4714TW:471437UnderperformTWD 2.37B-14.02―1.75%74.42%-247.01%

* General Sector Average

Performance Comparison

0%50%100%TW:6574TW:1325TW:2937TW:2942TW:4138TW:4714Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TW:6574 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TW:6574MIKOBEAUTE INTERNATIONAL CO., LTD.117.0044.1860.66%
TW:1325Universal Incorporation25.30-5.95-19.04%
TW:2937Gseven Co., Ltd.43.504.9712.89%
TW:2942Jing-Jan Retail Business Co., Ltd.34.305.5619.37%
TW:4138Dynamic Medical Technologies Inc.54.20-5.51-9.23%
TW:4714U-Best Innovative Technology Co.,Ltd10.80-6.12-36.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026